The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Translating Respiratory And Environmental Epidemiology Into Improved Lung Health
Funder
National Health and Medical Research Council
Funding Amount
$319,714.00
Summary
Chronic respiratory disease, tuberculosis and the effects of air pollution are important health problems globally. Evaluating current approaches to dealing with these problems and developing new approaches requires good data. Over the next five years I will lead a number of studies addressing these issues, in Australia and internationally, in order to provided the strongest possible evidence to underpin policy.
I am a developmental lung physiologist who specialises in understanding the factors regulating normal and abnormal lung development as well as the physiological transformation of the lung into an efficient gas-exchange organ at birth.
I am a developmental lung physiologist who specialises in understanding the factors regulating normal and abnormal lung development as well as the physiological transformation of the lung into an efficient gas-exchange organ at birth.
I am a pulmonary physician-gene therapist persuing new therapies for pulmonary vascular disease, lung cancer and mesothelioma, COPD and lung transplant rejection
I am a neonatologist interested in improving the outcomes of graduates of neonatal intensive care units. Currently the focus of my research is stabilisation immediately following birth and my research portfolio ranges from bench-top and animal studies thr
Professor Hoy has conducted precedent-setting research into chronic disease, especially in high risk populations, with a focus in Australia on Indigenous health. She is a role model for work amongst Indigenous people, specifically among Aboriginal people, and her work has been very influential, particularly in the training of staff. Professor Hoy’s Australia Fellowship will be used for an expanded multidisciplinary research program targeting the prevention and management of chronic diseases in t ....Professor Hoy has conducted precedent-setting research into chronic disease, especially in high risk populations, with a focus in Australia on Indigenous health. She is a role model for work amongst Indigenous people, specifically among Aboriginal people, and her work has been very influential, particularly in the training of staff. Professor Hoy’s Australia Fellowship will be used for an expanded multidisciplinary research program targeting the prevention and management of chronic diseases in the Aboriginal population, and focusing on hypertension, kidney disease, type 2 diabetes and cardiovascular disease.Read moreRead less
I am a scientist with a background in molecular and cellular pathology. My research relates to studies of animals models of diabetic kidney and heart disease focusing on the discovery of novel treatments.
I am a clinical researcher determining: a) the role of altered airway structure, particularly airway smooth muscle and extracellular matrix, in asthma and COPD; and b) the prevalence of, and risk factors for, respiratory disease in general populations.
Dr Reid is a respiratory physician determining the relationships between bacterial pathogen behaviour and the host immune response in Cystic Fibrosis. The aim of his research is to use observations made in the clinical setting to develop novel therapeutics and identification of biomarkers that will be employed to pre-empt and better treat clinical disease with the ultimate aim of improving length and quality of life.
I am a salaried-full time Physician in Respiratory Medicine at a major teaching hospital with postgraduate training, research experience and qualifications in clinical medicine and the epidemiology of occupational and environmental lung diseases and cance